Myriad Genetics, Inc. (OQ:MYGN)

INK Ultra Money Free

INK Ultra Money Premium

Get a Canadian Insider Club Ultra subscription for

  • Insider filing email alerts
  • Access to premium INK Research reports
  • Full access to weekly North America Top filer reports
  • Ad-free browsing
  • INK Ultra Money premium content

(already an Ultra member? Please log into your account for access)

Latest 10 SEC filings (by transaction date) for MYGN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 15th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 6/19 Dec 5/19 Newcomer Lee Nisley Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,687  
Dec 6/19 Dec 5/19 Phanstiel S. Louise Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,687  
Dec 6/19 Dec 5/19 Gilbert Walter Phd Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,687  
Dec 6/19 Dec 5/19 Dreismann Heinrich Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,687  
Dec 6/19 Dec 5/19 Langer Dennis Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,687  
Dec 6/19 Dec 5/19 Henderson John T Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,687  
Dec 6/19 Dec 5/19 Best Lawrence C Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,687  
Dec 6/19 Dec 5/19 Reitan Colleen F Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,687  
Nov 7/19 Nov 7/19 Henderson John T Indirect Ownership Common Stock P - Open market or private purchase 1,750 $23.46
Nov 7/19 Nov 7/19 Henderson John T Direct Ownership Common Stock P - Open market or private purchase 5,250 $23.46
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for MYGN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 15th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 6/19 Dec 5/19 Newcomer Lee Nisley Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,687  
Dec 6/19 Dec 5/19 Phanstiel S. Louise Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,687  
Dec 6/19 Dec 5/19 Gilbert Walter Phd Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,687  
Dec 6/19 Dec 5/19 Dreismann Heinrich Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,687  
Dec 6/19 Dec 5/19 Langer Dennis Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,687  
Dec 6/19 Dec 5/19 Henderson John T Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,687  
Dec 6/19 Dec 5/19 Best Lawrence C Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,687  
Dec 6/19 Dec 5/19 Reitan Colleen F Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,687  
Nov 7/19 Nov 7/19 Henderson John T Indirect Ownership Common Stock P - Open market or private purchase 1,750 $23.46
Nov 7/19 Nov 7/19 Henderson John T Direct Ownership Common Stock P - Open market or private purchase 5,250 $23.46
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $MYGN

Competitors

Competitors with Recent Insider Filings
Castle Biosciences (AR:CSTL)
Lantheus Holdings (OQ:LNTH)
VolitionRX (A:VNRX)